A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

NCT03990805 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2022-09-28

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

Conditions

Interventions

BIOLOGICAL

JOINTSTEM

JOINTSTEM Autologous Adipose Tissue derived MSCs 1x10\^8cells/(saline), 1 time injection

DRUG

saline

saline, 1 time injection

Sponsors & Collaborators

  • R-Bio

    lead INDUSTRY

Principal Investigators

  • KANGIL KIM, M.D., Ph.D. · KyungHee University Gangdong Hospital

  • WOOSUK LEE, M.D., Ph.D. · Gangnam Severance Hospital

  • SUNCHUL HWANG, M.D., Ph.D. · Gyeongsang National University Hospital

  • SANGJUN SONG, M.D., Ph.D. · Kyunghee University Medical Center

  • KICHEOR BAE, M.D., Ph.D. · Keimyung University Dongsan Medical Center

  • YOUNGWAN MOON, M.D., Ph.D. · Samsung Medical Center

  • JUHONG LEE, M.D., Ph.D. · Chonbuk National University Hospital

  • HANJUN LEE, M.D., Ph.D. · Chunang University Hospital

  • EUISUNG CHOI, M.D., Ph.D. · Chungbuk National University Hospital

  • YONG IN, M.D., Ph.D. · Seoul St. Mary's Hospital

  • KWANKYU PARK, M.D., Ph.D. · Yonsei University

  • OOGJIN SHON, M.D., Ph.D. · Yeungnam University Hospital

  • MYUNGCHUL LEE, M.D., Ph.D. · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-11
Primary Completion
2020-12-15
Completion
2020-12-15

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03990805 on ClinicalTrials.gov